Related Experiment Video

Updated: Jan 10, 2026

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.0K

Streptococcus pneumoniae diseases in Chinese children: past, present and future

Kai-Hu Yao1, Yong-Hong Yang

  • 1Beijing Children's Hospital Affiliated to Capital University of Medical Sciences, No. 56 Nan Lishi Road, Beijing 100045, PR China.

Vaccine
|July 8, 2008
PubMed

Insights

Pneumococcal diseases are a significant threat to children in China, caused by Streptococcus pneumoniae. Antimicrobial resistance is rising, necessitating further research for effective vaccine and antibiotic strategies.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Streptococcus pneumoniae (S. pneumoniae) is a major cause of pediatric infectious diseases, including meningitis and pneumonia, particularly in China.
  • Understanding the epidemiology of S. pneumoniae is crucial for public health interventions.

Observation:

  • Serotype distribution of S. pneumoniae exhibits significant diversity across different regions and time periods in China.
  • Penicillin non-susceptibility rates for S. pneumoniae have shown a concerning increase over time.
  • High prevalence rates (over 80%) of resistance to erythromycin, trimethoprim-sulfamethoxazole, and tetracycline were reported, exceeding those in developed nations.

Findings:

  • S. pneumoniae remains a critical pathogen in pediatric infections within China.
  • There is a notable trend of increasing antimicrobial resistance, particularly to penicillin, erythromycin, trimethoprim-sulfamethoxazole, and tetracycline.

Implications:

  • Future national surveys are essential to track serotype prevalence, antimicrobial resistance, and molecular epidemiology of S. pneumoniae.
  • Data on pneumococcal disease burden are needed to inform evidence-based guidelines for vaccine use and antibiotic treatment.
  • Addressing rising antimicrobial resistance is critical for managing pneumococcal infections in Chinese children.

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

2.0K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
702
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
762
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.5K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
731
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K